These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 19342454

  • 1. Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity.
    McEuen JG, Semsar KA, Lim MA, Bale TL.
    Endocrinology; 2009 Aug; 150(8):3709-16. PubMed ID: 19342454
    [Abstract] [Full Text] [Related]

  • 2. Corticotropin-releasing factor, serotonin, and sex: keys to the castle of depressive illness.
    Koenig JI.
    Endocrinology; 2009 Aug; 150(8):3440-2. PubMed ID: 19622778
    [No Abstract] [Full Text] [Related]

  • 3. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
    Jacobsen JP, Nielsen EØ, Hummel R, Redrobe JP, Mirza N, Weikop P.
    Psychopharmacology (Berl); 2008 Aug; 199(2):137-50. PubMed ID: 18496675
    [Abstract] [Full Text] [Related]

  • 4. Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function.
    Jin ZL, Chen XF, Ran YH, Li XR, Xiong J, Zheng YY, Gao NN, Li YF.
    Sci Rep; 2017 Aug 17; 7(1):8631. PubMed ID: 28819255
    [Abstract] [Full Text] [Related]

  • 5. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O, El Mansari M, Scarna H, Zimmer L, Sánchez C, Haddjeri N.
    Encephale; 2007 Dec 17; 33(6):965-72. PubMed ID: 18789789
    [Abstract] [Full Text] [Related]

  • 6. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse.
    Nackenoff AG, Moussa-Tooks AB, McMeekin AM, Veenstra-VanderWeele J, Blakely RD.
    Neuropsychopharmacology; 2016 Jun 17; 41(7):1733-41. PubMed ID: 26514584
    [Abstract] [Full Text] [Related]

  • 7. Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity.
    Bethea CL, Lima FB, Centeno ML, Weissheimer KV, Senashova O, Reddy AP, Cameron JL.
    J Chem Neuroanat; 2011 Jul 17; 41(4):200-18. PubMed ID: 21683135
    [Abstract] [Full Text] [Related]

  • 8. Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram.
    Zohar I, Dosoretz-Abittan L, Shoham S, Weinstock M.
    Psychopharmacology (Berl); 2015 May 17; 232(9):1643-53. PubMed ID: 25420605
    [Abstract] [Full Text] [Related]

  • 9. A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders.
    Olivier JD, Van Der Hart MG, Van Swelm RP, Dederen PJ, Homberg JR, Cremers T, Deen PM, Cuppen E, Cools AR, Ellenbroek BA.
    Neuroscience; 2008 Mar 27; 152(3):573-84. PubMed ID: 18295409
    [Abstract] [Full Text] [Related]

  • 10. Ontogeny of SERT Expression and Antidepressant-like Response to Escitalopram in Wild-Type and SERT Mutant Mice.
    Mitchell NC, Gould GG, Koek W, Daws LC.
    J Pharmacol Exp Ther; 2016 Aug 27; 358(2):271-81. PubMed ID: 27288483
    [Abstract] [Full Text] [Related]

  • 11. Perinatal citalopram does not prevent the effect of prenatal stress on anxiety, depressive-like behaviour and serotonergic transmission in adult rat offspring.
    Zohar I, Shoham S, Weinstock M.
    Eur J Neurosci; 2016 Feb 27; 43(4):590-600. PubMed ID: 26669896
    [Abstract] [Full Text] [Related]

  • 12. Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality.
    Pollier F, Sarre S, Aguerre S, Ebinger G, Mormède P, Michotte Y, Chaouloff F.
    Neuropsychopharmacology; 2000 Jan 27; 22(1):64-76. PubMed ID: 10633492
    [Abstract] [Full Text] [Related]

  • 13. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP, Mansari ME, Murphy DL, Blier P.
    Int J Neuropsychopharmacol; 2012 Apr 27; 15(3):349-61. PubMed ID: 21439106
    [Abstract] [Full Text] [Related]

  • 14. Expression and impact of Lsamp neural adhesion molecule in the serotonergic neurotransmission system.
    Bregin A, Kaare M, Jagomäe T, Karis K, Singh K, Laugus K, Innos J, Leidmaa E, Heinla I, Visnapuu T, Oja EM, Kõiv K, Lilleväli K, Harro J, Philips MA, Vasar E.
    Pharmacol Biochem Behav; 2020 Nov 27; 198():173017. PubMed ID: 32828972
    [Abstract] [Full Text] [Related]

  • 15. SK3 K+ channel-deficient mice have enhanced dopamine and serotonin release and altered emotional behaviors.
    Jacobsen JP, Weikop P, Hansen HH, Mikkelsen JD, Redrobe JP, Holst D, Bond CT, Adelman JP, Christophersen P, Mirza NR.
    Genes Brain Behav; 2008 Nov 27; 7(8):836-48. PubMed ID: 18616612
    [Abstract] [Full Text] [Related]

  • 16. Decreased Incentive Motivation Following Knockout or Acute Blockade of the Serotonin Transporter: Role of the 5-HT2C Receptor.
    Browne CJ, Fletcher PJ.
    Neuropsychopharmacology; 2016 Sep 27; 41(10):2566-76. PubMed ID: 27125304
    [Abstract] [Full Text] [Related]

  • 17. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.
    O'Leary OF, Bechtholt AJ, Crowley JJ, Hill TE, Page ME, Lucki I.
    Psychopharmacology (Berl); 2007 Jun 27; 192(3):357-71. PubMed ID: 17318507
    [Abstract] [Full Text] [Related]

  • 18. Effect of the fragrance inhalation of essential oil from Asarum heterotropoides on depression-like behaviors in mice.
    Park HJ, Lim EJ, Zhao RJ, Oh SR, Jung JW, Ahn EM, Lee ES, Koo JS, Kim HY, Chang S, Shim HS, Kim KJ, Gwak YS, Yang CH.
    BMC Complement Altern Med; 2015 Mar 06; 15():43. PubMed ID: 25881143
    [Abstract] [Full Text] [Related]

  • 19. Escitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.
    Flandreau EI, Bourke CH, Ressler KJ, Vale WW, Nemeroff CB, Owens MJ.
    Psychoneuroendocrinology; 2013 Aug 06; 38(8):1349-61. PubMed ID: 23267723
    [Abstract] [Full Text] [Related]

  • 20. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.
    Troelsen KB, Nielsen EØ, Mirza NR.
    Psychopharmacology (Berl); 2005 Oct 06; 181(4):741-50. PubMed ID: 16032412
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.